A raised uric acid result at a health assessment is not the same as a diagnosis of gout. Some people have a raised level without joint symptoms; others have repeated attacks that need a long-term treatment plan. The useful distinction is between an incidental blood finding, a current painful joint and established gout that is not yet controlled.
The Wellness offers doctor-led health assessments and results review in London. A focused consultation can connect the report with your joint history, kidney function, medicines and wider health. The aim is a clear explanation and an appropriate next step, with the scope and fee confirmed before booking.
Enquire about a raised uric acid result and a doctor-led review
What uric acid means on a blood report
Uric acid is a normal waste product formed when the body breaks down purines. Purines come from normal cell turnover as well as food and drink. The kidneys usually remove uric acid through the urine. A raised blood concentration can reflect increased production, reduced removal, or a combination of factors.
The same blood measurement may be called uric acid or serum urate. Results can be reported in micromol/litre or mg/dl, and laboratories use their own reference intervals. The original report, including its units and reference range, is more useful for review than a remembered number.
When urate crystals form in and around joints, they can cause gout. However, not everyone with a high blood level develops gout or kidney stones. The result is one part of the assessment, not a measure of how healthy every joint is or a prediction that an attack is inevitable.
A raised result without symptoms needs a different discussion
An incidental result in someone who has never had gout is often described as asymptomatic hyperuricaemia. It should be interpreted with the clinical history rather than automatically treated as active joint disease. Previous attacks matter, including episodes that settled before a diagnosis was made.
MedlinePlus explains that a high uric acid result does not always mean there is a condition needing treatment. The American College of Rheumatology's 2020 guideline conditionally recommends against starting urate-lowering medicine for asymptomatic hyperuricaemia. That is a US guideline recommendation for a defined group, not a universal instruction to ignore a raised result or stop an existing prescription.
In a London consultation, the doctor can establish whether that description actually fits. A history of gout attacks, tophi, kidney stones, kidney disease or a particular treatment context may change the discussion. People receiving cancer treatment have a separate reason for uric acid monitoring and should follow their treating team's instructions rather than a routine screening pathway.
A useful review therefore begins with the reason the test was taken, the actual level, earlier results and what has happened clinically. Repeating a broad panel without that context may add numbers without answering the original question.
Recognising a possible gout attack
Gout commonly causes rapid-onset, severe pain with swelling and warmth in a joint, often starting overnight. The big toe is a familiar site, but the ankle, midfoot, knee, hand, wrist and elbow can also be affected. Skin redness may be less visible on darker skin.
A sudden painful joint deserves assessment on its own merits. It should not be assumed to be gout simply because a previous blood test showed raised urate. NICE also advises considering joint infection, calcium pyrophosphate crystal deposition and inflammatory arthritis in a painful, red, swollen joint.
If pain and swelling are worsening, especially with fever, shivering, nausea or inability to eat, seek an urgent GP appointment or NHS 111 assessment. These can be signs of infection inside the joint. If septic arthritis is suspected, NICE recommends immediate referral through the local pathway. Do not wait for a routine health assessment or a WhatsApp response.
Why a blood test during a flare can be misleading
NICE recommends measuring serum urate in people with symptoms and signs of gout to support the clinical diagnosis, using a level of 360 micromol/litre, or 6 mg/dl, or above. This threshold belongs within the assessment of suspected gout; it is not a rule that everyone at that level has gout.
Serum urate can be below that threshold during an attack. If gout remains strongly suspected, NICE recommends repeating the measurement at least two weeks after the flare has settled. A result taken in the middle of a painful episode therefore cannot always settle the diagnosis.
When the diagnosis remains uncertain or unconfirmed, joint aspiration and microscopy of the fluid may be considered. If aspiration cannot be carried out, or uncertainty remains, imaging may help. NICE lists X-ray, ultrasound and dual-energy CT as options in the appropriate setting. The doctor selects the investigation that can answer the question; a routine blood result is not a reason to arrange every scan.
Discuss a uric acid result or a history of possible gout
Kidney function, medicines and the wider assessment
The kidneys help remove uric acid, so kidney function is relevant to interpretation and treatment. A review may connect urate with creatinine or eGFR, blood pressure, metabolic health and a history of stones. These are related clinical questions, not proof that a raised urate result has caused kidney or heart disease.
Medicines also matter. Diuretics and other treatments can affect the urate discussion; MedlinePlus notes that aspirin and niacin can affect test results. Bring the names and doses of prescribed medicines and supplements. Do not stop a prescribed treatment because of a blood-test flag or an online article.
A stone history may need its own assessment. Severe side or back pain, blood in the urine, vomiting, fever or difficulty passing urine should be assessed promptly rather than treated as a routine screening issue. A serum urate result alone does not establish what a stone is made of or exclude an obstructed or infected urinary tract.
At an executive health review, the value is in connecting these findings with the whole history. The doctor can distinguish something that needs confirming from a problem that needs treatment or specialist advice. A urate test, joint aspiration, scan or specialist consultation should not be assumed to be included unless the team confirms it.
Treating an attack and preventing attacks are different jobs
Treatment for an acute flare aims to control pain and inflammation. NICE recommends an NSAID, colchicine or a short course of oral corticosteroid as first-line options, taking account of other conditions, co-prescribed medicines and preferences. The right choice is individual, particularly where kidney disease or other medicines affect safety.
Long-term urate-lowering treatment has a different purpose: reducing the urate concentration so crystals can clear and future problems can be prevented. It is not simply an alternative painkiller to take when the joint hurts. The need for it depends on confirmed gout and the person's circumstances.
NICE recommends offering urate-lowering treatment to people with gout who have multiple or troublesome flares, CKD stages 3 to 5, diuretic therapy, tophi or chronic gouty arthritis. It also recommends discussing the option after a first or subsequent flare in people outside those groups. This makes follow-up after an attack worthwhile even when the pain has disappeared.
NICE generally recommends starting urate-lowering treatment at least two to four weeks after a flare settles; where flares are frequent, it can be started during a flare. Timing, medicine choice and protection against early flares should be agreed with the prescriber. This is not a reason to delay assessment of a painful joint or change an existing medicine yourself.
What a treat-to-target plan looks like
For established gout requiring urate-lowering medicine, NICE recommends starting at a low dose and using monthly serum urate measurements to guide dose increases, as tolerated, until the target is reached. The usual target is below 360 micromol/litre, or 6 mg/dl.
A lower target below 300 micromol/litre, or 5 mg/dl, can be considered with tophi, chronic gouty arthritis, or continuing frequent attacks despite a level below 360. These are treatment targets for gout, not universal screening targets for every healthy adult.
The plan should explain who reviews each result, how treatment changes are communicated and what to do if an attack or adverse effect occurs. NICE advises discussing preventive treatment for flares while urate-lowering medicine is started or increased. Reaching the target usually does not mean treatment can be stopped; NICE describes urate-lowering treatment as typically lifelong.
Once the target is reached and treatment continues, NICE recommends considering annual urate monitoring. Someone still having attacks, struggling with treatment or uncertain about the diagnosis may need earlier review. Referral to rheumatology can be considered when the diagnosis is uncertain, treatment is unsuitable or ineffective, or more complex kidney disease or a transplant affects care.
Food, alcohol and practical changes without blame
Gout is not adequately explained as the result of one meal or a lack of discipline. Genetics, kidney function, body weight, medicines and other conditions can all contribute. A balanced discussion is more useful than a restrictive diet imposed on the basis of a single test.
NICE says there is not enough evidence to show that a specific diet prevents flares or lowers serum urate. It recommends a healthy, balanced diet and explains that excess body weight and excessive alcohol may worsen flares and symptoms. Lifestyle measures support care; they do not replace indicated urate-lowering treatment.
The NHS also advises avoiding dehydration and crash diets. Practical changes can be fitted around travel, work and exercise, with advice adjusted if a clinician has restricted fluids for another condition. The aim is a sustainable plan, not a promise that avoiding a particular food will cure gout.
A doctor-led uric acid review with The Wellness
A health assessment with The Wellness brings the consultation, examination, appropriate investigations and results discussion into one plan. For an existing raised uric acid result, the first task is to establish what still needs explaining, rather than assume that more screening is always the answer.
The review can focus on the original report, previous results, any attacks of joint pain, kidney or stone history and current medicines. For confirmed gout, it can clarify the treatment target, monitoring and whether further assessment or referral is appropriate. The team confirms the appointment scope, testing arrangements, timing and fee before booking.
The benefit is continuity: an explanation of whether the finding is incidental, whether gout is likely or confirmed, and who owns the next step. A resolved attack should not leave an unresolved treatment plan, and a raised screening number should not become a diagnosis without the evidence.
Arrange an enquiry about uric acid or gout review in London
Frequently asked questions
Does raised uric acid mean I have gout?
No. Some people have raised uric acid without gout. The diagnosis depends on symptoms, examination and appropriate tests. A blood result alone does not establish the cause of a painful joint.
Can uric acid be normal during a gout attack?
Yes. If gout is strongly suspected despite a serum urate below 360 micromol/litre during a flare, NICE recommends repeating it at least two weeks after the flare has settled.
Do I need medicine for a raised result without symptoms?
Not automatically. The doctor needs to establish whether you have had gout, stones or another relevant condition. A raised result without symptoms is different from established gout and does not by itself justify starting or stopping medicine.
What urate target is used when treating gout?
NICE recommends below 360 micromol/litre, or 6 mg/dl, with a lower target below 300 micromol/litre considered for some people with more persistent or severe gout. These are treatment targets, not universal screening targets.
Can diet alone replace gout treatment?
A healthy, balanced diet and appropriate alcohol, weight and hydration advice can support care. NICE finds insufficient evidence that a specific diet prevents flares or lowers urate. Lifestyle measures do not replace medicine when it is clinically indicated.
When is a painful joint urgent?
Sudden swelling and pain that is worsening, especially with fever, shivering or feeling sick, needs urgent assessment because joint infection can resemble gout. In the UK, seek an urgent GP appointment or NHS 111 help rather than waiting for routine screening.
Enquire about a doctor-led uric acid results review
This article provides general information and does not replace individual medical advice. Diagnosis, investigations, treatment and referral depend on clinical assessment.